ArticleSensors (Basel, Switzerland)2025
Unsupervised Domain Adaptation with Raman Spectroscopy for Rapid Autoimmune Disease Diagnosis.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Autoimmune diseases constitute a broadly prevalent category of disorders. Conventional computer-aided diagnostic (CAD) techniques rely on large volumes of data paired with reliable annotations. However, the diverse symptomatology and diagnostic complexity of autoimmune diseases result in a scarcity of reliably labeled biological samples. In this study, we propose a pseudo-label-based conditional domain adversarial network (CDAN-PL) framework by integrating Raman spectroscopy with domain adaptation technology, enabling label-free unsupervised transfer diagnosis of diseases. Compared to traditional unsupervised domain adaptation techniques, our CDAN-PL framework generates reliable pseudo-labels to ensure the robust implementation of conditional adversarial methods. Additionally, its spectral data-adaptive feature extraction techniques further solidify the model's superiority in Raman spectroscopy-based disease diagnosis. CDAN-PL exhibits excellent performance in homologous transfer tasks, achieving an average accuracy of 92.3%-surpassing the baseline models' 80.81% and 86.4%. Moreover, it attains an average accuracy of 90.05% in non-homologous transfer tasks, further validating its generalization capability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.